Orphanbiotec AG

Development and implementation of new medications for rare diseases

Orphanbiotec works on the development and implementation of new medications for Rare Diseases. Our nature based pharmaceutical solutions create affordable therapies for Rare Diseases in a sustainable and profitable manner through the repositioning of approved substances. The company was founded in January 2009. Orphanbiotec AG is a Swiss Start-up company, which works in a unique hybrid partnership with the charitable Foundation Orphanhealthcare. Orphanbiotec engages in delivering sustainable, financial and social impact to patients & investors.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
REGISTER

No news

No milestones

No Jobs

No Awards

Orphanbiotec AG

Development and implementation of new medications for rare diseases

Website:
www.orphanbiotec.com

Headquarter:
Zürich

Foundation Date:
January 2009

Technology:

  • Biotech

Sectors:

  • Biomaterials
  • Cancer
  • Drug development platforms
  • Drug discovery
  • Inflammation
  • Screening

Support received

  • Support venturelab